Chapter 21 – Multiple Sclerosis and Depression: A Neuroimmunological Perspective

作者: Barry G. Arnason

DOI: 10.1016/S1567-7443(10)70026-0

关键词:

摘要: Publisher Summary This chapter examines whether depression is coincidental with multiple sclerosis (MS), or if it a symptom, consequence, side effect of the treatment, some combination these. The also explores antecedent risk factors, such as previous psychiatric history, family history affective disorder, influence prevalence both before and during discusses likely causes in MS population. exceeds 100 cases per 100,000 persons many parts world, including much Europe North America. early onset (typically between 20 40 years age), lifelong duration, unpredictable course result major burdens to individual, society, well reduced quality life work productivity. Depression perhaps recognized less often than should be. A depression-triggered negativistic mindset, seldom acknowledged, usual reason for refusal start immunomodulatory treatment. negatively impacts compliance once treatment has begun.

参考文章(446)
David Michelson, Barbara Misiewicz-Poltorak, Richard B. Raybourne, Philip W. Gold, Esther M. Sternberg, Imipramine reduces the local inflammatory response to carrageenin Agents and Actions. ,vol. 42, pp. 25- 28 ,(1994) , 10.1007/BF02014295
S Lanquillon, Cytokine Production and Treatment Response in Major Depressive Disorder Neuropsychopharmacology. ,vol. 22, pp. 370- 379 ,(2000) , 10.1016/S0893-133X(99)00134-7
Audrey R. Tyrka, Linda L. Carpenter, Christopher J. McDougle, Paul D. Kirwin, Michael J. Owens, Charles B. Nemeroff, David R. Strong, Lawrence H. Price, Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults. Biological Psychiatry. ,vol. 56, pp. 531- 534 ,(2004) , 10.1016/J.BIOPSYCH.2004.06.035
F. T. Bergh, T. Kumpfel, C. Trenkwalder, R. Rupprecht, F. Holsboer, Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS Neurology. ,vol. 53, pp. 772- 777 ,(1999) , 10.1212/WNL.53.4.772
Sinead M. O'Brien, Lucinda V. Scott, Timothy G. Dinan, Cytokines: abnormalities in major depression and implications for pharmacological treatment Human Psychopharmacology-clinical and Experimental. ,vol. 19, pp. 397- 403 ,(2004) , 10.1002/HUP.609
N. I. Landro, H. Sletvold, E. G. Celius, Memory Functioning and Emotional Changes in Early Phase Multiple Sclerosis Archives of Clinical Neuropsychology. ,vol. 15, pp. 37- 46 ,(2000) , 10.1093/ARCLIN/15.1.37
Kenichi Sakurai, Jian-Ping Zou, Jolynne R. Tschetter, Jerrold M. Ward, Gene M. Shearer, Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. ,vol. 129, pp. 186- 196 ,(2002) , 10.1016/S0165-5728(02)00176-5
J.P. Leonard, F.J. MacKenzie, H.A. Patel, M.L. Cuzner, Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis Brain, Behavior, and Immunity. ,vol. 5, pp. 328- 338 ,(1991) , 10.1016/0889-1591(91)90028-9
Yonit Bomstein, Jonathan B. Marder, Karen Vitner, Igor Smirnov, Galit Lisaey, Oleg Butovsky, Valentin Fulga, Eti Yoles, Features of skin-coincubated macrophages that promote recovery from spinal cord injury. Journal of Neuroimmunology. ,vol. 142, pp. 10- 16 ,(2003) , 10.1016/S0165-5728(03)00260-1
A Huang, D Fuchs, B Widner, C Glover, D C Henderson, T G Allen-Mersh, Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer British Journal of Cancer. ,vol. 86, pp. 1691- 1696 ,(2002) , 10.1038/SJ.BJC.6600336